Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs

Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs

Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey caught up with Winkler to discuss: - The origins and science behind weight loss drugs. - The challenge of selling lizard venom research to pharmaceutical companies. - What decades-old research on anglerfish reveals about modern side effects for Ozempic. - And why it’s “not too hard” to keep dozens of Gila Monsters in your basement. “Monster Diet Drugs Like Ozempic Started With Actual Monsters”: https://www.wsj.com/articles/ozempic-mounjaro-gila-monster-anglerfish-8c9c1ff2 Companies mentioned: NVO, LLY Host: Ricky Mulvey Guest: Rolfe Winkler Engineers: Tim Sparks, Heather Horton Learn more about your ad choices. Visit megaphone.fm/adchoices

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(2322)

Is the Data Center Investing Trend in Trouble?

Is the Data Center Investing Trend in Trouble?

Description: Snowflake stock is surging towards all-time highs after reporting its latest quarterly earnings, and on today’s show, Jon, Matt, and Lou break down what’s going right for the company in c...

3 Sep 25min

Tesla Robotaxi Day & the Competition’s Response

Tesla Robotaxi Day & the Competition’s Response

Tesla is having a Robotaxi day tomorrow and we still don’t know details about the event. But that doesn’t mean investors aren’t expecting a lot nearly two years after the Robotaxi was first announced....

2 Sep 18min

Big Tech Gets the Regulatory Shakedown

Big Tech Gets the Regulatory Shakedown

Amazon and Meta Platforms are facing increased scrutiny from regulators and states and that’s not only affecting their stock price, it could affect their business long-term. We discuss whether FTC pro...

1 Sep 19min

A $13 Billion Bet on Robots?

A $13 Billion Bet on Robots?

Hugging Face is pushing forward open-source large-language models, which potentially keep closed AI models from becoming too powerful. Now Hugging Face is pushing open-source robotic software with its...

31 Aug 28min

Not All Revenue Growth Is Created Equal — A Harvard Fellow's Framework for Spotting the Real Thing

Not All Revenue Growth Is Created Equal — A Harvard Fellow's Framework for Spotting the Real Thing

Wall Street treats demand like a line on a chart. Rob Snyder says that's exactly why investors keep getting burned. Motley Fool analyst Rachel Warren talks with Rob Snyder — Harvard Innovation Labs ...

30 Aug 21min

Prepare to Pass on Your Possessions

Prepare to Pass on Your Possessions

n this next installment of our 2026 Financial Planning Challenge, host Robert Brokamp is joined by fellow Fool Stephanie Marini to discuss the most unpleasant area of financial planning: estate planni...

29 Aug 28min

Jensen Huang's AI Capex Pulse Check

Jensen Huang's AI Capex Pulse Check

Nvidia's Jensen Huang stunned investors with a bold prediction for AI capex spending, and Marvell's blowout earnings seem to back him up. Plus, CrowdStrike's "Mythos moment" is reshaping the cybersecu...

28 Aug 40min

NVIDIA Earnings Blow Everyone Away

NVIDIA Earnings Blow Everyone Away

With a company as large and as meticulously covered as NVIDIA, you would think there wouldn’t be anything that surprises us anymore. So much for that thesis. NVIDIA's most recent earnings and guidance...

27 Aug 28min

Populärt inom Business & ekonomi

framgangspodden
rss-jossan-nina
varvet
rss-borsens-finest
badfluence
uppgang-och-fall
avanzapodden
svd-tech-brief
24fragor
rss-kort-lang-analyspodden-fran-di
lastbilspodden
rikatillsammans-om-privatekonomi-rikedom-i-livet
tabberaset
rss-inga-dumma-fragor-om-pengar
bathina-en-podcast
fill-or-kill
rss-dagen-med-di
rss-hos-psykologen
kapitalet-en-podd-om-ekonomi
rss-sparpodden-2